EE04330B1 - Levosimendani transmukoossed koostised ja nende kasutamine ravimi valmistamiseks - Google Patents

Levosimendani transmukoossed koostised ja nende kasutamine ravimi valmistamiseks

Info

Publication number
EE04330B1
EE04330B1 EEP200000368A EEP200000368A EE04330B1 EE 04330 B1 EE04330 B1 EE 04330B1 EE P200000368 A EEP200000368 A EE P200000368A EE P200000368 A EEP200000368 A EE P200000368A EE 04330 B1 EE04330 B1 EE 04330B1
Authority
EE
Estonia
Prior art keywords
levosimendan
medicament
manufacture
patient
source
Prior art date
Application number
EEP200000368A
Other languages
English (en)
Estonian (et)
Inventor
Oiva Antero Kurkela Kauko
Marvola Martti
Larma Ilkka
Virtanen Raimo
Karlsson Marianne
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of EE200000368A publication Critical patent/EE200000368A/xx
Publication of EE04330B1 publication Critical patent/EE04330B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Otolaryngology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Paper (AREA)
  • Air Bags (AREA)
EEP200000368A 1997-12-19 1998-12-11 Levosimendani transmukoossed koostised ja nende kasutamine ravimi valmistamiseks EE04330B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI974578A FI974578L (fi) 1997-12-19 1997-12-19 Menetelmä levosimendaanin antamiseksi
PCT/FI1998/000977 WO1999032081A1 (en) 1997-12-19 1998-12-11 Transmucosal formulations of levosimendan

Publications (2)

Publication Number Publication Date
EE200000368A EE200000368A (et) 2001-10-15
EE04330B1 true EE04330B1 (et) 2004-08-16

Family

ID=8550178

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000368A EE04330B1 (et) 1997-12-19 1998-12-11 Levosimendani transmukoossed koostised ja nende kasutamine ravimi valmistamiseks

Country Status (26)

Country Link
US (1) US6399610B1 (cs)
EP (1) EP1052973B1 (cs)
JP (1) JP2001526205A (cs)
KR (1) KR100753689B1 (cs)
AT (1) ATE215358T1 (cs)
AU (1) AU738082B2 (cs)
BR (1) BR9813641A (cs)
CA (1) CA2313618C (cs)
CZ (1) CZ296693B6 (cs)
DE (1) DE69804678T2 (cs)
DK (1) DK1052973T3 (cs)
EA (1) EA002197B1 (cs)
EE (1) EE04330B1 (cs)
ES (1) ES2175827T3 (cs)
FI (1) FI974578L (cs)
HR (1) HRP20000400B1 (cs)
HU (1) HU226736B1 (cs)
IL (1) IL136415A (cs)
NO (1) NO320050B1 (cs)
NZ (1) NZ504806A (cs)
PL (1) PL191868B1 (cs)
PT (1) PT1052973E (cs)
RS (1) RS49889B (cs)
SK (1) SK284838B6 (cs)
WO (1) WO1999032081A1 (cs)
ZA (1) ZA9811405B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI980901A7 (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
FI20002755A0 (fi) 2000-12-15 2000-12-15 Orion Yhtymae Oyj Menetelmä erektiilin dysfunktion hoitamiseen
CN100428937C (zh) * 2003-10-30 2008-10-29 北京海合天科技开发有限公司 左西孟旦冷冻干燥组合物
FI20040674A0 (fi) * 2004-05-12 2004-05-12 Orion Corp Menetelmä tromboembolisten sairauksien estoon
EP2767163A1 (en) * 2005-02-17 2014-08-20 Abbott Laboratories Transmucosal administration of drug compositions for treating and preventing disorders in animals
US20070010518A1 (en) * 2005-02-18 2007-01-11 Matti Kivikko Method for administering levosimendan
WO2007096906A2 (en) * 2006-02-27 2007-08-30 Panacea Biotec Ltd. Novel buccoadhesive compositions and process of preparation thereof
KR20090055606A (ko) * 2006-09-27 2009-06-02 니코노범 에이비 지향성 용도
US11523986B2 (en) * 2019-03-22 2022-12-13 Dbbh, Llc Intranasally administered antihistamines and uses thereof
CA3145456A1 (en) * 2019-07-01 2021-01-07 Orion Corporation Methods for administering (r)-n-[4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl]acetamide
JP2023507626A (ja) 2019-12-16 2023-02-24 テナックス・セラピューティクス，インコーポレイテッド 駆出率が保たれた心不全を伴う肺高血圧症（ＰＨ－ＨＦ－ｐＥＦ）を治療するためのレボシメンダン

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) * 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
US5688520A (en) * 1995-03-29 1997-11-18 Minnesota Mining And Manufacturing Company Transmucosal delivery of melatonin for prevention of migraine
GB9614098D0 (en) 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan

Also Published As

Publication number Publication date
WO1999032081A1 (en) 1999-07-01
US6399610B1 (en) 2002-06-04
FI974578A7 (fi) 1999-06-20
DE69804678D1 (de) 2002-05-08
ZA9811405B (en) 1999-06-11
ATE215358T1 (de) 2002-04-15
IL136415A (en) 2005-03-20
EA200000686A1 (ru) 2000-12-25
NO20003059D0 (no) 2000-06-14
RS49889B (sr) 2008-08-07
HU226736B1 (en) 2009-08-28
SK284838B6 (sk) 2005-12-01
CA2313618A1 (en) 1999-07-01
EP1052973A1 (en) 2000-11-22
YU36900A (sh) 2003-02-28
NO320050B1 (no) 2005-10-17
BR9813641A (pt) 2000-10-17
NZ504806A (en) 2001-09-28
SK9062000A3 (en) 2000-12-11
KR100753689B1 (ko) 2007-08-30
KR20010033368A (ko) 2001-04-25
HRP20000400B1 (hr) 2009-06-30
DK1052973T3 (da) 2002-04-29
FI974578L (fi) 1999-06-20
EA002197B1 (ru) 2002-02-28
FI974578A0 (fi) 1997-12-19
HRP20000400A2 (en) 2000-12-31
PT1052973E (pt) 2002-09-30
DE69804678T2 (de) 2002-11-21
HUP0100452A3 (en) 2002-03-28
PL191868B1 (pl) 2006-07-31
PL341202A1 (en) 2001-03-26
ES2175827T3 (es) 2002-11-16
CZ296693B6 (cs) 2006-05-17
CA2313618C (en) 2008-02-05
AU738082B2 (en) 2001-09-06
AU1565699A (en) 1999-07-12
CZ20002155A3 (cs) 2000-11-15
EP1052973B1 (en) 2002-04-03
IL136415A0 (en) 2001-06-14
NO20003059L (no) 2000-06-14
JP2001526205A (ja) 2001-12-18
HUP0100452A2 (hu) 2002-02-28
EE200000368A (et) 2001-10-15

Similar Documents

Publication Publication Date Title
AU1079701A (en) Oral transmucosal drug dosage using solid solution
KR970703151A (ko) 알렌드로네이트의 경구 액상 제형(Oral liquid alendronate formulations)
ES2172510T3 (es) Nueva combinacion de formoterol y budesonida.
ATE264102T1 (de) Nicotin enthaltende pharmazeutische zusammensetzungen mit schneller transmukosaler absorption
CY1105707T1 (el) Συνδυασμοι φορμοτερολης και ενος αλατος τριοτροπιου
SE9703191D0 (sv) Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases
WO1998035658A3 (de) Verwendung von 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzochinon
DE69804678D1 (de) Transmukosale levosimendanformulierungen
BG104797A (en) Use of dexmedetomi dine for sedative effect in patients in an intensive care unit
NO994257D0 (no) Anvendelse av levobupivakain ved ansiktskirurgi
DK0927031T3 (da) Farmaceutisk sammensætning indeholdende nimesulid til oral admnistration
RU97115801A (ru) Способ лечения стенозирующих ларинготрахеитов у детей
JPS59155318A (ja) 細胞の活性剤とその活用方法
MD1469G2 (ro) Metodă de tratament al şocului combustional
TR200102221T2 (tr) Kalp krizi sonrası tedavileri için moksonidin kullanımı
RU97116821A (ru) Способ лечения респираторных заболеваний
UA41652A (uk) Спосіб лікування хворих на гіпертонічну хворобу

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

GB1A Change in the ownership or in the address of the owner
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20101211